Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
24.20
+1.51 (6.65%)
At close: Oct 8, 2025, 4:00 PM EDT
24.35
+0.15 (0.62%)
After-hours: Oct 8, 2025, 7:55 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Novel Immunotherapies
10.59M
Log In
Log In
Log In
Novel Immunotherapies Growth
30.99%
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
10.59M
Log In
Log In
Log In
United States Growth
30.99%
Log In
Log In
Log In